Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001493152-25-001857
Filing Date
2025-01-13
Accepted
2025-01-13 07:00:20
Documents
18
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 form10-ka.htm   iXBRL 10-K/A 233663
2 ex31-1.htm EX-31.1 13016
3 ex31-2.htm EX-31.2 16138
4 ex32-1.htm EX-32.1 7218
5 ex32-2.htm EX-32.2 7057
6 form10-ka_001.jpg GRAPHIC 2207
  Complete submission text file 0001493152-25-001857.txt   532621

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE hepa-20231231.xsd EX-101.SCH 3027
8 XBRL LABEL FILE hepa-20231231_lab.xml EX-101.LAB 36320
9 XBRL PRESENTATION FILE hepa-20231231_pre.xml EX-101.PRE 23778
20 EXTRACTED XBRL INSTANCE DOCUMENT form10-ka_htm.xml XML 7521
Mailing Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837
Business Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837 732-902-4000
Hepion Pharmaceuticals, Inc. (Filer) CIK: 0001583771 (see all company filings)

EIN.: 462783806 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-36856 | Film No.: 25524734
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)